Physician profile
John James Pearce
NPI 1639661283
$62,775.03
in general payments reported to CMS, 2019-2025
16 companies · $40K in 2025
The $40K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $140 · 2021: $20K · 2022: $397 · 2023: $1,389 · 2024: $509 · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $39K · Food and Beverage: $2,113 · Education: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $39,090.91 |
| Food and Beverage | $2,113.10 |
| Education | $345.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,000.00 | 2021-2025 | Vercise |
| Medtronic, INC. | $21,190.95 | 2023-2025 | Activa PC, Infinity Occipitocervical Upper Thoracic System, Visualase |
| Abbott Laboratories | $9,170.86 | 2023-2025 | Infinity |
| Medical Device Business Services, INC. | $545.99 | 2022-2023 | |
| Si-Bone, INC. | $425.45 | 2020-2021 | |
| Nuvasive, INC. | $405.88 | 2023 | Pcm, Xlif, Mlx |
| Stryker Corporation | $191.51 | 2019-2024 | N/A, Core, Prolift |
| Depuy Synthes Sales INC. | $143.87 | 2022 | |
| Qapel Medical INC | $141.68 | 2024 | |
| Livanova USA, INC. | $141.12 | 2021 | |
| Medtronic USA, INC. | $129.49 | 2019 | |
| Zimmer Biomet Holdings, INC. | $106.73 | 2019 | |
| Spinal Elements, INC. | $60.30 | 2023 | |
| Gt Medical Technologies, INC | $53.36 | 2022 | |
| Integra Lifesciences Corporation | $51.41 | 2024 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $16.43 | 2024 | Neuroblate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pearce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.